Single-Cell RNA Sequencing Reveals Melanoma Cell State-Dependent Heterogeneity of Response to MAPK Inhibitors

Investigators applied single-cell RNA sequencing to interrogate the molecular features of immunotherapy-naive and immunotherapy-resistant melanoma tumours in response to ex vivo BRAF/MEK inhibitor treatment.